Introduction of Maribavir Anti-infective into Upper GI, Via Natural or Artificial Opening, New Technology Group 8 Code History

Introduction of Fostamatinib into Mouth and Pharynx, External Approach, New Technology Group 7 Code History

Introduction of SER-109 into Mouth and Pharynx, External Approach, New Technology Group 9 Code History

Introduction of Baricitinib into Mouth and Pharynx, External Approach, New Technology Group 6 Code History

Introduction of Sabizabulin into Mouth and Pharynx, External Approach, New Technology Group 8 Code History

Introduction of Quizartinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 9 Code History

Introduction of Other New Technology Therapeutic Substance into Mouth and Pharynx, External Approach, New Technology Group 5 Code History

Introduction of Uridine Triacetate into Mouth and Pharynx, External Approach, New Technology Group 2 Code History

Introduction of Lefamulin Anti-infective into Mouth and Pharynx, External Approach, New Technology Group 6 Code History